Epidemiology and disease burden of pathologic myopia and myopic choroidal neovascularization: an evidence-based systematic review.
By Tien Yin Wong, Alberto Ferreira, R. Hughes, G. Carter, P. Mitchell. American journal of ophthalmology-glaucoma, 2014
700 citations recorded by the source corpus.
Subfields: Epidemiology, Ophthalmology
View Paper: https://www.semanticscholar.org/paper/bf0539dfa8289439012b0c520c8458e9a58bbda4
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Epidemiology
Citations in the corpus
- Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050. (2016, unknown): “However, myopia brings further vision challenges because high myopia increases the risk of pathologic ocular changes such as cataract, glaucoma, retinal detachment, and myopic macular degeneration, all of which can cause irreversible vision loss.(4) In some communities with a”
- Five-Year Clinical Trial on Atropine for the Treatment of Myopia 2: Myopia Control with Atropine 0.01% Eyedrops. (2016, background): “Given the increasing prevalence of myopia in East Asia, where the prevalence of myopia in young adults now approaches 80% and high myopia rates exceed 20%, it is thought that the disease burden and cost of pathologic myopia will continue to increase over time.(27) The availability of an effective an”